PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation

被引:0
|
作者
Sabbatino, Francesco [1 ]
Wang, Yangyang [1 ]
Wang, Xinhui [1 ]
Flaherty, Keith T. [1 ]
Pepin, David [1 ]
Scognamiglio, Giosue [2 ]
Yu, Ling [3 ]
Cooper, Zachary A. [4 ]
Pepe, Stefano [5 ]
Kirkwood, John M. [6 ]
Frederick, Dennie T. [1 ]
Wargo, Jennifer A. [4 ]
Ferrone, Soldano [1 ]
Ferrone, Cristina R. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy
[3] Southwest Univ, Inst Clean Energy & Adv Mat, Chongqing, Peoples R China
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Salerno, I-84100 Salerno, Italy
[6] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
关键词
D O I
10.1158/1538-7445.AM2014-3703
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3703
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells -: Role of BRAF mutation and fibroblast growth factor signaling
    Huntington, JT
    Shields, JM
    Der, CJ
    Wyatt, CA
    Benbow, U
    Slingluff, CL
    Brinckerhoff, CE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (32) : 33168 - 33176
  • [42] The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition
    Amaral, Teresa
    Sinnberg, Tobias
    Meier, Friedegund
    Krepler, Clemens
    Levesque, Mitchell
    Niessner, Heike
    Garbe, Claus
    EUROPEAN JOURNAL OF CANCER, 2017, 73 : 85 - 92
  • [43] Zeaxanthin from Porphyridium purpureum induces apoptosis in human melanoma cells expressing the oncogenic BRAF V600E mutation and sensitizes them to the BRAF inhibitor vemurafenib
    Camille Juin
    Raimundo Gonçalves de Oliveira Junior
    Audrey Fleury
    Chloé Oudinet
    Lior Pytowski
    Jean-Baptiste Bérard
    Elodie Nicolau
    Valérie Thiéry
    Isabelle Lanneluc
    Laureen Beaugeard
    Grégoire Prunier
    Jackson Roberto Guedes Da Silva Almeida
    Laurent Picot
    Revista Brasileira de Farmacognosia, 2018, 28 : 457 - 467
  • [44] Zeaxanthin from Porphyridium purpureum induces apoptosis in human melanoma cells expressing the oncogenic BRAF V600E mutation and sensitizes them to the BRAF inhibitor vemurafenib
    Juin, Camille
    de Oliveira Junior, Raimundo Gonsalves
    Fleury, Audrey
    Oudinet, Chloe
    Pytowski, Lior
    Berard, Jean-Baptiste
    Nicolau, Elodie
    Thiery, Valerie
    Lanneluc, Isabelle
    Beaugeard, Laureen
    Prunier, Gregoire
    Guedes Da Silva Almeida, Jackson Roberto
    Picot, Laurent
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2018, 28 (04): : 457 - 467
  • [45] GSK3-beta activation is a key driver of resistance to RAF inhibition in BRAF mutant melanoma cells
    Crisan, D.
    Scharffetter-Kochanek, K.
    Zhao, F.
    Paschen, A.
    Schatz, S.
    Hainzl, H.
    Baican, A.
    Crisan, M.
    Basu, A.
    Sindrilaru, A.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E30 - E30
  • [46] MEK Pathway Inhibitor-Mediated Response in BRAF V600-Mutant Melanoma with Brain Parenchymal and Leptomeningeal Metastases
    Alhusaini, Saud
    Naya, Lewis
    Reddy, Sunil A.
    Patel, Chirag B.
    ANNALS OF NEUROLOGY, 2024, 96 (06) : 1227 - 1229
  • [47] Differential gene induction by genetic and ligand-mediated activation of the Sonic hedgehog pathway in neural stem cells
    Galvin, Katherine E.
    Ye, Hong
    Wetmore, Cynthia
    DEVELOPMENTAL BIOLOGY, 2007, 308 (02) : 331 - 342
  • [48] The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors
    Delmas, Audrey
    Cherier, Julia
    Pohorecka, Magdalena
    Medale-Giamarchi, Claire
    Meyer, Nicolas
    Casanova, Anne
    Sordet, Olivier
    Lamant, Laurence
    Savina, Ariel
    Pradines, Anne
    Favre, Gilles
    ONCOTARGET, 2015, 6 (17) : 15250 - 15264
  • [49] Activation of the mitogen-activated protein kinase pathway in malignant melanoma can occur independently of the BRAF T1799A mutation
    Yazdi, Amir S.
    Ghoreschi, Kamran
    Sander, Christian A.
    Roecken, Martin
    EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (05) : 575 - 579
  • [50] Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor
    Caporali, Simona
    Alvino, Ester
    Lacal, Pedro Miguel
    Levati, Lauretta
    Giurato, Giorgio
    Memoli, Domenico
    Caprini, Elisabetta
    Cappellini, Gian Carlo Antonini
    D'atri, Stefania
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) : 1164 - 1174